Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P050017/S025

Zilver Flex 35 Vascular Stent

Cook Ireland, Ltd. · Decision date Oct 22, 2025

FDA DECISIONP050017/S025

What did the FDA approve?

FDA records P050017/S025 as a supplement to PMA P050017, with the supplement type “Special (Immediate Track)”. The recorded decision is approval, dated Oct 22, 2025.

FDA approval order statement

requested updates to your device labeling, including the graphics, operating principles, precautions and procedural instructions
Regulatory pathway
PMA supplement
Supplement type
Special (Immediate Track)
Clinical specialty
Cardiovascular
Decision date
Oct 22, 2025
FDA change category
Labeling Change - Indications/instructions/shelf life/tradename

FDA source record

Regulatory record facts

Identifier
P050017/S025
Regulatory pathway
PMA supplement
Product code
NIO
Decision code
APPR
Decision date
Oct 22, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: STENT, ILIAC.

Product code
NIO
FDA device class
3

For the original device and its historical approval scope, see PMA P050017. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P050017 · Original PMA

    ZILVER VASCULAR STENT

  2. P050017/S025 received

    Application receipt date recorded by FDA.

  3. P050017/S025 · FDA decision

    Special (Immediate Track)

  4. P050017/S026 · Related supplement

    Zilver Flex 35 Vascular Stent; Zilver 635 Vascular Stent; Zilver 518 Vascular Stent

  5. P050017/S027 · Related supplement

    Zilver 635 Vascular Stent, Zilver 518 Vascular Stent

Timeline entries are records held by MedtechLedger for P050017. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P050017

Product / regulatory recordCompanyPathwayDecision dateSource
Cook Ireland, Ltd.PMA approvalJun 26, 2006FDA
Cook Ireland, Ltd.PMA supplementApr 14, 2026FDA
Cook Ireland, Ltd.PMA supplementNov 6, 2026FDA

Explore the linked device profile

Other records with product code NIO

Product / regulatory recordCompanyPathwayDecision dateSource
Medtronic Vascular, Inc.PMA supplementOct 16, 2026FDA
Cordis US CorporationPMA supplementOct 15, 2026FDA
Biotronik AGPMA supplementSep 11, 2026FDA
Boston Scientific CorpPMA supplementAug 21, 2026FDA
Boston Scientific CorpPMA supplementAug 6, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Cook Ireland, Ltd.

Headquarters
Not reported
Brand website
cookmedical.com
FDA applicant address
O' Halloran Rd., National Technology Park, Limerick

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records